Table 5.
Measurement properties | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Reference | Content validity | Structural validity | Internal consistency | Reliability | Measurement error | Hypothesis testing | Criterion validity | Responsiveness | Cross‐cultural validity | |
Generic | EQ‐5D | |||||||||
16 | Fair | |||||||||
17 | Fair | |||||||||
SF‐36 | ||||||||||
16 | Fair | |||||||||
WHOQOL‐BREF | ||||||||||
18 | Poor | |||||||||
Cancer generic | EORTC QLQ‐C30 | |||||||||
19 | Good | Good | ||||||||
17 | Fair | |||||||||
20 | Fair | |||||||||
Bladder Cancer | BCI | |||||||||
23 | Fair | |||||||||
22 | Excellent | Good | Good | Fair | Fair | |||||
16 | Poor | Poor | Fair | Fair | Poor | |||||
24 | Fair | Fair | ||||||||
25 | Poor | Fair | Fair | Poor | ||||||
21 | Poor | |||||||||
FACT‐Bl | ||||||||||
16 | Fair | |||||||||
26 | Poor | |||||||||
27 | Poor | Poor | ||||||||
28 | Poor | |||||||||
MIBC | FACT‐VCI | |||||||||
29 | Good | Good | Fair | Poor | Fair | |||||
30 | Poor | Poor | Fair | Fair | ||||||
31 | Poor | Poor | Fair | Poor | ||||||
21 | Poor | |||||||||
IONB‐PRO | ||||||||||
32 | Excellent | Fair | Fair | Poor | Fair | |||||
EORTC QLQ‐BLM30 | ||||||||||
17 | Poor | Fair | ||||||||
Untitled | ||||||||||
36 | Excellent | Poor | Poor | |||||||
37 | Poor | |||||||||
38 | Excellent | Poor | ||||||||
35 | Excellent | Poor | Poor | Poor | ||||||
NMIBC | EORTC QLQ‐NMIBC24 | |||||||||
19 | Poor | Good | Good | |||||||
34 | Fair | Fair | Fair | |||||||
CAVICAVENMI | ||||||||||
33 | Excellent | Good | Poor | Poor | Fair |